CTAS
42
2
TSCO
48
5
AXP
67
4
KLAC
59
3
MA
64
2
HP
38
4
AMP
50
3
MCO
73
5
AIG
38
2
EMR
62
6
MUR
43
3
GT
47
4
HST
57
4
ADM
27
2
PAYX
45
6
CAG
36
2
DHR
40
5
TRV
42
5
TXN
35
5
SRE
47
7
CTAS
42
2
TSCO
48
5
AXP
67
4
KLAC
59
3
MA
64
2
HP
38
4
AMP
50
3
MCO
73
5
AIG
38
2
EMR
62
6
MUR
43
3
GT
47
4
HST
57
4
ADM
27
2
PAYX
45
6
CAG
36
2
DHR
40
5
TRV
42
5
TXN
35
5
SRE
47
7
Financhill
Back

Viking Therapeutics Vs. Nukkleus Industry Stock Comparison

Sell
24

VKTX
Viking Therapeutics

Last Price:
$42.71
Seasonality Move:
21.99%
Sell
46

NUKK
Nukkleus

Last Price:
$39.21
Seasonality Move:
-19.41%
Sell
24
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $42.35. The Score for VKTX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $36.51. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $42.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $36.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.05 Sell
Relative Strength Index (14 RSI): 34.2 Sell
Chaikin Money Flow: 146451 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.46 - 52.88) Sell
Bollinger Bands (100): (50.86 - 67.3) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.05 Buy
Relative Strength Index (14 RSI): 70.65 Buy
Chaikin Money Flow: -185340 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-6.64 - 27.72) Buy
Bollinger Bands (100): (-4.95 - 13.67) Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.46 Sell
20-day SMA: 47.87 Sell
50-day SMA: 56.89 Sell
200-day SMA: 61.45 Sell
8-day EMA: 43.58 Sell
20-day EMA: 47.31 Sell
50-day EMA: 53.29 Sell
200-day EMA: 54.12 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.48 Buy
20-day SMA: 12.75 Buy
50-day SMA: 6.46 Buy
200-day SMA: 5.1 Buy
8-day EMA: 31.37 Buy
20-day EMA: 18.71 Buy
50-day EMA: 9.9 Buy
200-day EMA: 12.32 Buy

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):